Immunological effect of tyrosine kinase inhibitors on the tumor immune environment in non-small cell lung cancer

Acquired resistance to tyrosine kinase inhibitors (TKIs) limits the duration of antitumor effects and impairs the survival of patients with oncogene-driven non-small cell lung cancer (NSCLC). At present, little is known about the immunomodulatory ability of TKIs during the entire treatment period, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Li, Liu, Jiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988264/
https://www.ncbi.nlm.nih.gov/pubmed/35414830
http://dx.doi.org/10.3892/ol.2022.13285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988264/
https://www.ncbi.nlm.nih.gov/pubmed/35414830
http://dx.doi.org/10.3892/ol.2022.13285

Ejemplares similares